Group subscription

AFT grows share price with US market approval

+News

AFT grows share price with US market approval

Jonathan Chilton Towle 2019

Jonathan Chilton-Towle

Friday 10 March 2023, 01:54 PM
Founder of AFT Pharmaceuticals
AFT managing director Hartley Atkinson [Image: Supplied]
The New Zealand share market has reacted positively to the news that AFT Pharmaceuticals’ flagship product Maxigesic was approved for sale in the US.
Related Articles
Undoctored

Maxigesic Rapid® tablets gain US FDA approval

Media release from AFT Pharmaceuticals
Friday 10 March 2023

News archive

How to Treat

Eczema

Paediatric eczema

Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management

Read more
Wednesday 14 August 2024, 12:45 AM
More How to Treat

Latest news

Primary care in commissioner’s diary

23/08/2024

‘Very humbled’: PHO boss Mark Vella makes top three finalists for innovation leadership award

23/08/2024

New paramedic scheme in north Coromandel has GP support

23/08/2024

Health researchers blame politicians for funding shortfall

23/08/2024

Solutions for after-hours crisis called for in major Southern rural review

22/08/2024

Pharmacist wants lawmakers to tread carefully with roadside drug-testing changes

22/08/2024

Events

GP Connect 2024 Conference

-
Wellington
view more events

Latest issue

NZ Doctor 14th August 2024 Front Cover

14 August 2024

View all issues

That's interesting

Brain stimulation technique may give more relief from Parkinson’s symptoms - The Guardian
Bay of Islands Hospital doctors speak out as new patients to be turned away: 'We are now at our limit' - RNZ
Scientists hail ‘smart’ insulin that responds to changing blood sugar levels in real time - The Guardian
More That's Interesting